256 related articles for article (PubMed ID: 8968650)
41. [Combining effectiveness and tolerance].
Krankenpfl J; 2005; 43(1-3):26-7. PubMed ID: 15912821
[No Abstract] [Full Text] [Related]
42. Schizophrenia: attitudes of patients and professional carers towards the illness and antipsychotic medication.
Rettenbacher MA; Burns T; Kemmler G; Fleischhacker WW
Pharmacopsychiatry; 2004 May; 37(3):103-9. PubMed ID: 15138893
[TBL] [Abstract][Full Text] [Related]
43. [Compliance in therapy of schizophrenic patients with neuroleptics--an overview].
Mayer C; Soyka M
Fortschr Neurol Psychiatr; 1992 Jun; 60(6):217-22. PubMed ID: 1353747
[TBL] [Abstract][Full Text] [Related]
44. Quality of life in schizophrenia: the impact of psychopathology, attitude toward medication, and side effects.
Hofer A; Kemmler G; Eder U; Edlinger M; Hummer M; Fleischhacker WW
J Clin Psychiatry; 2004 Jul; 65(7):932-9. PubMed ID: 15291682
[TBL] [Abstract][Full Text] [Related]
45. Management of treatment resistant schizophrenia unresponsive to clozapine.
Barnes TR; McEvedy CJ; Nelson HE
Br J Psychiatry Suppl; 1996 Dec; (31):31-40. PubMed ID: 8968653
[No Abstract] [Full Text] [Related]
46. [Co-enaesthetic schizophrenia. Case studies of illness perception and compliance].
Schmoll D
Fortschr Neurol Psychiatr; 1994 Oct; 62(10):372-8. PubMed ID: 8001893
[TBL] [Abstract][Full Text] [Related]
47. Schizophrenic patients' subjective reasons for compliance and noncompliance with neuroleptic treatment.
Löffler W; Kilian R; Toumi M; Angermeyer MC
Pharmacopsychiatry; 2003 May; 36(3):105-12. PubMed ID: 12806568
[TBL] [Abstract][Full Text] [Related]
48. [Better prognosis due to new treatment approaches. Therapy of schizophrenia in 2002].
Janssen B; Gaebel W
MMW Fortschr Med; 2002 May; Suppl 2():72-6, 78. PubMed ID: 12070858
[TBL] [Abstract][Full Text] [Related]
49. Comparison of patient and clinician perspectives in the assessment of antipsychotic medication adherence.
Barbui C; Kikkert M; Mazzi MA; Becker T; Bindman J; Schene A; Nosè M; Helm H; Thornicroft G; Tansella M
Psychopathology; 2009; 42(5):311-7. PubMed ID: 19672133
[TBL] [Abstract][Full Text] [Related]
50. [Effect of neuroleptics on depressive symptoms].
Tabeze JP
Encephale; 1998 Jul; 24 Spec No 1():38-41. PubMed ID: 9809254
[No Abstract] [Full Text] [Related]
51. The CATIE study and its implications for antipsychotic drug use.
Janicak PG
Essent Psychopharmacol; 2006; 7(1):53-63. PubMed ID: 16989293
[No Abstract] [Full Text] [Related]
52. [Factors related to treatment adherence in schizophrenic patients].
García Cabeza I; Sánchez Díaz EI; Sanz Amador M; Gutiérrez Rodríguez M; González de Chávez M
Actas Esp Psiquiatr; 1999; 27(4):211-6. PubMed ID: 10469940
[TBL] [Abstract][Full Text] [Related]
53. The management of difficult to treat patients with schizophrenia, using non-drug therapies.
Kuipers E
Br J Psychiatry Suppl; 1996 Dec; (31):41-51. PubMed ID: 8968654
[No Abstract] [Full Text] [Related]
54. Perspectives on treatment needs in schizophrenia.
Meise U; Fleischhacker WW
Br J Psychiatry Suppl; 1996 May; (29):9-16. PubMed ID: 8733818
[No Abstract] [Full Text] [Related]
55. Experience with a drug-free month in schizophrenic outpatients.
Heinrichs DW; Carpenter WT
Psychopharmacol Bull; 1985; 21(1):117-9. PubMed ID: 2858904
[No Abstract] [Full Text] [Related]
56. Proceedings: Butaclamol in the treatment of schizophrenia--a comparison of two treatment methods.
Imaz F; Ban TA; Lehmann HE
Psychopharmacol Bull; 1976 Jan; 12(1):31-4. PubMed ID: 1826
[No Abstract] [Full Text] [Related]
57. Antipsychotic effects of AL 1965.
Sathananthan G; Mir P; Gershon S
Curr Ther Res Clin Exp; 1976 May; 19(5):516-9. PubMed ID: 7435
[No Abstract] [Full Text] [Related]
58. Comparing symptom response among antipsychotic medications in CATIE.
Levine SZ; Rabinowitz J; Ascher-Svanum H; Faries DE; Lawson AH
J Clin Psychopharmacol; 2013 Feb; 33(1):123-6. PubMed ID: 23288232
[No Abstract] [Full Text] [Related]
59. Piperacetazine in ambulatory chronic schizophrenic patients.
Rada RT; Donlon PT
Curr Ther Res Clin Exp; 1974 Feb; 16(2):124-9. PubMed ID: 4156665
[No Abstract] [Full Text] [Related]
60. Cognitive behavior therapy for schizophrenia: a meta-analytical review of randomized controlled trials.
Sarin F; Wallin L; Widerlöv B
Nord J Psychiatry; 2011 Jun; 65(3):162-74. PubMed ID: 21563994
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
